Ligand Pharmaceuticals Inc. (LGND)

Last Three Months

22-Aug-24 -- 21-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Manufacturers - Other

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

43

0

0

+1

0

+2

0

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
24-Sep-24 7:41 PM View:	20-Sep-24 Sale ($132.52K)	Espinoza Octavio Chief Financial Officer		Ligand Pharmaceuticals Inc. - LGND	4% 23.65K to 24.61K	0	0	--	--	Show Txns Hide Txns

24-Sep-24 7:41 PM View:	23-Sep-24 Sale ($39.98K)	Korenberg Matthew E President & COO		Ligand Pharmaceuticals Inc. - LGND	(26%) 68.37K to 50.78K	0	0	--	--	Show Txns Hide Txns

25-Sep-24 8:54 PM View:	23-Sep-24 Option Sale ($199.20K)	Reardon Andrew CLO & Secretary		Ligand Pharmaceuticals Inc. - LGND	0% 22.53K	0	0	--	--	Show Txns Hide Txns